First-line pembrolizumab and trastuzumab in HER2-positive oesophageal, gastric, or gastro-oesophageal junction cancer: an open-label, single-arm, phase 2 trial
Titel:
First-line pembrolizumab and trastuzumab in HER2-positive oesophageal, gastric, or gastro-oesophageal junction cancer: an open-label, single-arm, phase 2 trial
Auteur:
Janjigian, Yelena Y Maron, Steven B Chatila, Walid K Millang, Brittanie Chavan, Shweta S Alterman, Carly Chou, Joanne F Segal, Michal F Simmons, Marc Z Momtaz, Parisa Shcherba, Marina Ku, Geoffrey Y Zervoudakis, Alice Won, Elizabeth S Kelsen, David P Ilson, David H Nagy, Rebecca J Lanman, Richard B Ptashkin, Ryan N Donoghue, Mark T A Capanu, Marinela Taylor, Barry S Solit, David B Schultz, Nikolaus Hechtman, Jaclyn F